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SINE transcription by RNA polymerase III is
suppressed by histone methylation but not by
DNA methylation
Dhaval Varshney1,2,*, Jana Vavrova-Anderson1,*, Andrew J. Oler3,4, Victoria H. Cowling2, Bradley R. Cairns3,4 &
Robert J. White1,5
Short interspersed nuclear elements (SINEs), such as Alu, spread by retrotransposition, which
requires their transcripts to be copied into DNA and then inserted into new chromosomal
sites. This can lead to genetic damage through insertional mutagenesis and chromosomal
rearrangements between non-allelic SINEs at distinct loci. SINE DNA is heavily methylated
and this was thought to suppress its accessibility and transcription, thereby protecting against
retrotransposition. Here we provide several lines of evidence that methylated SINE DNA is
occupied by RNA polymerase III, including the use of high-throughput bisulphite sequencing
of ChIP DNA. We find that loss of DNA methylation has little effect on accessibility of SINEs
to transcription machinery or their expression in vivo. In contrast, a histone methyltransferase
inhibitor selectively promotes SINE expression and occupancy by RNA polymerase III.
The data suggest that methylation of histones rather than DNA plays a dominant role in
suppressing SINE transcription.
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A
striking feature of mammalian chromosomes is the large
numbers of short interspersed nuclear elements (SINEs)
interspersed among the genes. For example, the human
genome carries B106 copies of Alu SINEs that together account
for B11% of total chromosomal DNA. Such SINEs have had a
major impact on genomic evolution and place a burden on
chromosomal stability through deletions and translocations
arising by recombination between non-allelic loci. Indeed, SINEs
have caused many instances of human genetic disease1,2,
including a-thalassaemia3, hypercholesterolaemia4 and neuro-
fibromatosis5.
SINEs spread by retrotransposition, which requires their
transcripts to be copied into DNA and then inserted into new
chromosomal sites. SINE promoters direct transcription by RNA
polymerase (pol) III, but expression is extremely weak. For
example, the million Alu templates together produce only B103
transcripts in HeLa cells, whereas the three 7SL genes per genome
produce B106 transcripts using the same pol III transcription
factors as Alu6. It was estimated that B99% of potentially active
Alu SINEs with intact promoters may be silenced7. Such
transcriptional repression is believed to involve packaging the
SINEs into chromatin structures that deny access of transcription
factors. This may be of great importance, because SINEs can exert
boundary effects and regulate messenger RNA (mRNA)
synthesis8. SINE transcript overexpression can be cytotoxic and
cause an untreatable form of human blindness9.
SINE transcription is thought to be silenced through methyla-
tion of CpG, an important mechanism of gene repression in
mammals10,11. About 7 million of the total 30 million CpG sites
in the human genome lie within Alu sequences12, with CpG
densities ninefold above the average for the human genome in
some subfamilies13. Heavy methylation is found at the majority
of Alu and mouse SINEs14–16. That this contributes to
transcriptional repression was suggested by an increase in Alu
expression after treatment of HeLa cells with the DNA
methylation inhibitor 5-azacytidine6. Furthermore, methylation
of Alu DNA was found to repress its transcription in transient
transfections and in vitro under some conditions13,15,17.
Repression in vitro was relieved by miscellaneous methylated
competitor DNA, suggesting that it is mediated by one or more
trans-acting factors with sequence independent affinity for
methylated DNA13. Examples of such methyl-CpG-binding
proteins (MBPs) include MeCP2, MBD1 and MBD2, which
operate primarily by directing assembly of repressive chromatin
structures that are inaccessible to the transcription machinery18.
Indeed, MeCP2 was found at Alu SINEs in human cells19.
Here we show that human and mouse SINE families are
occupied by MeCP2, MBD1 and MBD2. However, SINE
transcription is not enhanced by DNA demethylation and release
of these MBPs. In contrast, pol III loading and expression of
SINEs increases significantly when cells are treated with
chaetocin, a selective inhibitor of SUV39 methyltransferases that
methylates histone H3 on lysine 9 (H3K9). Endogenous SUV39
associates with SINEs and SINE induction by chaetocin correlates
with loss of trimethylated H3K9. The data suggest that
methylation of H3K9, rather than DNA, is primarily responsible
for suppressing pol III-mediated transcription of genomic SINEs
in the cells we have studied.
Results
MBPs target SINEs. Consistent with the model that SINEs
are subject to MBP-mediated silencing, semiquantitative and
quantitative chromatin immunoprecipitation (ChIP)–PCR assays
detected MeCP2, MBD1 and MBD2 in HeLa cells at multiple Alu
sites, chosen randomly from several chromosomes (Fig. 1a,b).
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Figure 1 | SINEs provide binding sites for MBPs. (a) Semiquantitative ChIP
assay in HeLa cells showing the binding of MBD1, MBD2 and MeCP2 at Alu
loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci. Alu19J
is also from chromosome 19. ChIPs for histone H3 and TAFI48 provide positive
and negative controls, respectively. No antibody was used for the mock
sample. (b) Mean±s.e.m. of the percentage input bound in two independent
ChIP–quantitative PCR assays with HeLa cells and antibodies against histone
H3, TAFI48, MBD1, MBD2 and MeCP2, as indicated. No antibody was used for
the mock samples. Amplifications were carried out using primers for the Apo-E
and 7SL genes, Alu PV subfamily consensus sequence and individual Alus on
chromosomes 6, 10, 19 and 22, as indicated. (c) Semiquantitative ChIP assay
in A31 fibroblasts showing binding of MBD1, MBD2 and MeCP2 at B1 and B2
loci, as well as 7SL and Apo-E genes. B1 and B2 consensus primers match
B102 members of the B1 and B2 families, whereas B1(c9) and B2(c9) primers
detect unique loci on chromosome 9. ChIPs for histone H3 and TAFI48
provide positive and negative controls, respectively.
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These Alus have 7–13 CpGs each and include an example from
chromosome 6 (c6) that is embedded in a cluster of SINEs,B5 kb
from the nearest annotated pol II-transcribed gene. Binding was
also detected using consensus primers that recognize B103
members of an Alu subfamily. Signal intensity is comparable to
that obtained with the pol II-dependent Apo-E gene, which is
known to be silenced by MBPs20. Furthermore, binding is
selective, as it was not observed at 7SL genes, the ancestral
progenitors of Alu21. In contrast to SINEs, 7SL sequences are
predominantly unmethylated in genomic DNA.
In rodent genomes, the most abundant SINE families are B1
and B2, instead of Alu22. Whereas B1 resembles Alu, both having
evolved from 7SL RNA, B2 is unrelated and derived from a
transfer RNA (tRNA)21,23. Nevertheless, both B1 and B2 SINEs
are occupied by MeCP2, MBD1 and MBD2 in mouse fibroblasts
(Fig. 1c). In each case, clear binding was detected using primers
that recognise familial consensus sequences, as well as with
unique loci from chromosome 9 (c9). We conclude that abundant
mouse and human SINEs are targeted by proteins that mediate
transcriptional silencing directed by DNA methylation.
MBPs do not exclude pol III from SINEs. Despite the presence
of MBPs, pol III was also detected at these SINEs, as were the pol
III-specific transcription factors TFIIIB and TFIIIC (Fig. 2a,b).
Specificity was confirmed by the lack of pol III, TFIIIB and
TFIIIC at the pol II-dependent Apo-E gene. ChIP–quantitative
PCR demonstrated that pol III detection at consensus Alu
elements is approximately sixfold weaker than at the highly active
7SL genes, but is nevertheless significantly above the background
observed on the Apo-E gene or with a negative control antibody
against TAFI48, a pol I-specific transcription factor (Fig. 2c). We
conclude that chromosomal SINEs are more accessible to pol III
and its associated transcription factors than had previously been
thought.
The clear detection of both pol III and MBPs at these loci could
be explained if a mixed cell population was present, with the same
SINE occupied by MBPs in some cells and by pol III machinery in
others. Sequential ChIP assays were used to test this hypothesis.
DNA occupied by pol III was immunoprecipitated and the
samples were then re-immunoprecipitated with antibodies to
MeCP2, MBD1 and MBD2, as well as TFIIIB and pol III again as
positive controls. For each MBP tested, Alu DNA was recovered
at the levels well above background, indicating that all three
MBPs can interact with a SINE at the same time as
pol III (Fig. 2d). This was also the case for B1 and B2 SINEs
and when TFIIIC was chromatin immunoprecipitated first
instead of pol III (Supplementary Fig. 1).
Co-occupancy of MBPs with pol III and its associated factors
suggests that the latter can bind to methylated DNA. This
possibility is supported by ChIP–chop assays, in which DNA
recovered from ChIP samples is subjected to restriction digestion
at sequences of potential methylation24. As expected, Alu DNA
associated with MBD2 or MeCP2 was digested more readily by
the methylation-insensitive restriction enzyme MspI than by its
methylation-sensitive isoschizomer HpaII (Supplementary Fig. 2).
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Figure 2 | Pol III co-occupies methylated SINEs with MBPs. (a) Semiquantitative ChIP assay in A31 fibroblasts showing specific binding of TFIIIB, TFIIIC
and pol III to B1 and B2 loci, as well as 7SL, but not the Apo-E gene. Histone H3 and TAFI48 provide positive and negative controls, respectively.
(b) Semiquantitative ChIP assay in HeLa cells showing occupancy of pol III, TFIIIB and TFIIIC at Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL
and Apo-E genes. ChIPs for histone H3 and TAFI48 provide positive and negative controls, respectively. No antibody was used for the mock sample.
(c) Mean±s.e.m. of the percentage input bound in three independent ChIP–quantitative PCR (qPCR) assays in HeLa cells, of the indicated proteins at
individual Alu loci from chromosomes 6, 10, 19 and 22, as well as 7SL and Apo-E loci and Alu PV subfamily consensus. ChIPs for histone H3 and TAFI48
provide positive and negative controls, respectively. No antibody was used for the mock samples. P values are calculated by t-test. (d) Mean±s.e.m. of four
independent sequential ChIP–qPCR assays in which DNA immunoprecipitated from HeLa cells using pol III antibody was reprecipitated using antibodies
against pol III, TFIIIB, TAFI48 (negative control), MBD1, MBD2 and MeCP2, as indicated. No TAFI48 signal was detected on Alu(c6).
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The same was found for Alu DNA bound by pol III or TFIIIC,
demonstrating that these proteins also interact in vivo with
methylated SINE DNA.
Bisulphite sequencing of a pol III-bound Alu following ChIP
demonstrated the high levels of CpG methylation (Supplementary
Fig. 3). To examine this globally, we applied the recently reported
genome-scale ChIP-bisulphite-sequencing (ChIP-BS-Seq) techni-
que to assess DNA methylation status of pol III-bound DNA25.
Using this method, we found that the methylation levels are
comparable for input DNA and for Alu DNA cross-linked to pol
III, showing that DNA methylation does not deter occupancy
(Fig. 3a). This is the case for all Alu classes, including the
relatively young AluY subclasses that are most active in
retrotransposition. Indeed, the AluY SINEs generally show
significantly higher DNA methylation than the older AluS and
AluJ classes, and also higher pol III occupancy, although the latter
does not reach statistical significance (Supplementary Data 1
provides the full data set). The AluYa5 subclass has the highest
occupancy by pol III, despite being one of the most strongly
methylated (Fig. 3b). Inverse correlation was not found between
pol III occupancy and DNA methylation. Focusing on the
B-block region, which provides the primary, high-affinity binding
site for TFIIIC, comparison of the three main classes revealed
CpG methylation of 55–65% for AluY, compared with 30–50%
for AluS and 13% for AluJ, the oldest Alu class. It is striking that
the A- and B-block promoter regions that direct transcription
complex assembly contain CpG dinucleotides that are methylated
in pol III-bound DNA at comparable levels to the input DNA
(Fig. 3c; Supplementary Fig 4). Indeed, 12.9% of Alu SINEs show
statistically significant enrichment for CpG methylation in the
pol III ChIP relative to the input DNA, whereas this is only the
case for 0.4% of tRNA genes. Overall, Alu SINEs have much
higher levels of CpG methylation than tRNA genes, irrespective
of whether they are occupied by pol III (Fig. 3d). Collectively, the
data indicate that template methylation does not prevent access of
pol III to SINEs. Furthermore, pol III can be detected throughout
the length of occupied SINEs (Supplementary Fig 5).
We tested the effect on pol III occupancy of treating cells with
5-azacytidine at concentrations that elicit global genomic
demethylation. The efficacy of the treatment was confirmed by
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a clear decrease in MBP binding in vivo (Fig. 4a,b) and was
confirmed in vitro following extraction of genomic DNA
(Supplementary Fig. 6). However, pol III detection at Alu, B1
and B2 SINEs was not increased, providing further evidence that
DNA methylation does not preclude access of pol III to SINEs
(Fig. 4a,b). Detection of TFIIIB and TFIIIC at SINEs is also
unaffected by 5-azacytidine (Fig. 4b). To address the possibility
that CpG demethylation might affect the distribution of pol III
along its template, we included primers located downstream of an
Alu. As expected, the signal for TFIIIB is weaker using the
downstream primers, whereas robust signals from pol III and
TFIIIC are maintained; this is consistent with the established
localization of these proteins26. As with other primer sets, the
pol III signal with the downstream primer set was not
significantly affected by 5-azacytidine (Fig. 4b). Although the
shortness of SINEs limits the study of polymerase distribution
using this technology, the available data do not support the
possibility that demethylation alters pol III positioning along
SINE DNA.
We also found comparable levels of SINE occupancy by pol III
between fibroblasts with or without targeted disruption of the
gene encoding Dnmt1 (Fig. 4c), despite the fact that the Dnmt1-
knockout cells have o5% of the normal level of DNA
methylation27. The ChIP signals from TFIIIB and TFIIIC on
SINEs are also comparable in the presence or absence of Dnmt1.
Although expression of MBD2 and MeCP2 is undiminished in
the knockout cells, their binding to B1 and B2 loci is significantly
compromised (Fig. 4c; Supplementary Fig. 7). This observation
excludes the unlikely possibility that methylation of B1 or B2
DNA is immune to loss of Dnmt1. We conclude that pol III and
its associated transcription factors are not prevented from
accessing SINEs in vivo by DNA methylation or the presence of
various MBPs.
SINE repression does not rely on DNA methylation. Dnmt1-
knockout fibroblasts show little or no increase in B1 or B2 RNA
(Fig. 5a), despite robust induction of the Apo-E and p53BP2
genes, both of which are subject to methylation-dependent
silencing20,28. This is consistent with a previous report that the
B1 transcript levels are unchanged relative to wild type in
Dnmt1 / or Dnmt3ab / embryonic stem (ES) cells, in
which CpG methylation of B1 DNA is reduced by approximately
two- to fourfold29.
Because SINEs are often located within introns and untrans-
lated regions of protein-coding genes, SINE sequences are found
within many longer pol II-derived RNAs. As this can complicate
interpretation, we applied a-amanitin at a concentration that
inhibits pol II while allowing transcription by pol III. Again we
found no evidence that B1 or B2 expression is elevated in
Dnmt1 / fibroblasts relative to wild type (Supplementary
Fig. 8). This is consistent with the unchanged occupancy by
pol III, TFIIIB and TFIIIC, as determined by ChIP (Fig. 4c).
As knockout cells have the potential to adapt to permanent loss
of a component, we also used 5-azacytidine to promote DNA
demethylation in wild-type cells. This caused no increase in the
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expression of B1 or B2 transcripts in ES cells (Fig. 5b). Similarly,
Alu expression was not increased when HeLa cells were treated
with 5-azacytidine (Fig. 5c). In both cases, efficacy of the
treatment was confirmed by induction of Apo-E mRNA in the
same samples. It was also demonstrated by the release of MBD2
and MeCP2 from B1, B2 and Alu SINEs (Fig. 4a,b). The fact that
pol III occupancy did not increase is consistent with the absence
of increased expression. Indeed, small but consistent decreases
were seen in pol III binding and transcript expression; the reason
for this has not been pursued.
PCR with reverse transcription (RT–PCR) does not distinguish
between transcripts synthesized by pol III from a SINE’s own
promoter and pol II-derived RNAs that contain SINE sequences
due to the fortuitous presence of these transposable elements
in protein-coding genes. We were concerned that a change in
pol III-mediated transcription of SINEs might be masked in
this assay by constant expression of SINE-containing pol II
transcripts. However, the use of a pol III-specific inhibitor
established that this is not the case and that the contribution
of pol III to the total levels of SINE RNA is detectable using our
RT–PCR assay (Supplementary Fig. 9). Nevertheless, primer
extension was used to focus on transcripts that initiate specifically
at the pol III transcription start site and distinguish these from
read-through transcripts initiated upstream6. Transcripts detected
by this approach are Alu-specific and resistant to doses of
a-amanitin that inhibit pol II transcription (Supplementary
Figs 10,11). Primer extension assays showed that 5-azacytidine
treatment makes no significant difference (P¼ 0.54, t-test) to the
expression of Alu RNA that initiates at the pol III start site,
although significantly (P¼ 0.000065, t-test) enhancing Apo-E
expression (Fig. 5d; Supplementary Fig. 12). We conclude that
DNA methylation does not suppress the occupancy or activity of
pol III at SINEs, despite attracting MBPs to these loci.
SUV39H1 suppresses pol III occupancy and expression of SINEs.
Multiple Alu sequences were recovered in a low-throughput
genomic screen of sites bound by K9-methylated histone H3
(ref. 30). Indeed, 68% of the clones isolated either contained Alu
sequence or were o200 bp from one30. This constitutes a strong
enrichment, since Alu provides B11% of genomic DNA.
Consistent with this, the Alu loci we tested show clear
trimethylation of histone H3 lysine 9 (H3K9me3; Fig. 6a;
Supplementary Fig. 13). In contrast, H3K9me3 is close to
background at active 7SL genes.
One of the enzymes that methylates H3K9 is SUV39H1
(ref. 31). That this histone methyltransferase might mediate SINE
repression was suggested by the fact that a dominant-negative
Suv39h mutant stimulates the expression of B1 and B2 RNA29.
We detected SUV39H1 at several Alu loci (Alus c10, c19 and
c22), but an example was also found (Alu(c6)) where H3K9me3
does not correlate with detection of SUV39H1 (Fig. 6a;
Supplementary Fig. 13). SUV39H1 was also detected at the p21
promoter, one of its documented targets32, but was close to
background at 7SL genes. The combined presence of methylated
H3K9 and SUV39H1 has been shown to recruit HP1 (ref. 33).
Accordingly, HP1 was detected at the p21 promoter and Alu loci
with SUV39H1 and H3K9me3, but not at 7SL or Alu(c6) where
SUV39H1 is absent. When cells were treated with chaetocin, a
selective inhibitor of the SUV39 family34, H3K9me3 levels
decreased specifically at the Alu sites where SUV39H1 was
detected (Fig. 6b; Supplementary Fig. 14). We conclude that
SUV39H1 trimethylates H3K9 at some Alu loci, but is not
unique in this regard. SUV39H1 is one of several H3K9
methyltransferases35,36.
At tRNA genes, H3K9me3 shows a strong inverse correlation
with pol III occupancy37,38. Consistent with this, pol III binding
to Alu DNA is increased by chaetocin, but only at the loci where
H3K9me3 decreases (Fig. 6b; Supplementary Fig. 14). The action
of chaetocin is specific, as it increases pol III binding significantly
without affecting the binding of TFIIIC or total histone H3.
Furthermore, these effects were only observed at loci where
SUV39H1 was detected. Elevated Alu expression was observed
in chaetocin-treated cells (Fig. 6c) and primer extension
demonstrated increased use of the Alu pol III initiation sites
(Fig. 6d). The fact that Alu RNA increases when 7SL RNA does
not provides evidence that detection of Alu expression is not
masked in our assays by the highly abundant 7SL transcript.
The data suggest that H3K9me3 is inhibitory to pol III
recruitment and therefore contributes to suppression of SINE
transcription. To test whether this mark on SINEs depends on
methylation of their DNA, we examined its presence in
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Figure 5 | SINE expression is not stimulated by loss of DNA methylation.
(a) Analysis by semiquantitative RT–PCR of expression levels of the
indicated transcripts in matched Dnmt1þ /þ and Dnmt1 / fibroblasts.
Duplicate samples are shown for both cell types. Apo-E and p53BP2
mRNAs provide controls that have been documented as being suppressed
by DNA methylation. GAPDH mRNA provides a loading control.
(b) Analysis by semiquantitative RT–PCR of expression levels of the
indicated transcripts in mouse ES cells treated for 16 h with (þ ) or without
( ) 5-azacytidine. Apo-E mRNA provides a control that has been
documented as being inhibited by DNA methylation. ARPP P0 mRNA
provides a loading control. (c) Analysis by semiquantitative RT–PCR of
expression levels of the indicated transcripts in HeLa cells treated for
72 h with 5-azacytidine. Apo-E mRNA provides a control that has been
documented as being inhibited by DNA methylation. ARPP P0 mRNA
provides a loading control. (d) Analysis by primer extension of Alu
transcripts in the RNA from Fig. 5c. Bracket indicates B240bp products
that initiate at the principle pol III start site of Alu. Reverse transcriptase
was omitted from the reactions in lanes 1 and 2. To confirm that the assay
was not saturated, raising the amount of template RNA from 5 (lanes 5 and
6) to 10 mg (lanes 3 and 4) is shown to give a stronger signal. Alu, B1 and B2
RT–PCRs were performed with Alu, B1 and B2 consensus primers,
respectively (Supplementary Table 1).
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fibroblasts with targeted disruption of Dnmt1. Despite the495%
decrease in DNA methylation27, H3K9me3 was clearly detected at
B1 and B2 SINEs in the Dnmt1-null cells (Fig. 7a). Furthermore,
5-azacytidine treatment did not significantly decrease the levels of
H3K9me3 or SUV39H1 on B1, B2 or Alu SINEs in ES or HeLa
cells, although MBD2 binding decreased (Fig. 7b; Supplementary
Figs 15,16). In contrast to 5-azacytidine, chaetocin treatment
stimulated pol III occupancy and the expression of both B1 and
B2 in the presence or absence of Dnmt1 (Fig. 7c,d). These data
suggest that SUV39H1 inhibits recruitment of pol III and
transcription of SINEs independently of DNA methylation.
DNA methylation suppresses translocation between Alu SINEs.
Cytosine methylation has been shown to inhibit homologous
recombination between satellite DNA and its deficiency can cause
human genetic disease39. We therefore considered whether SINE
methylation might protect the genome by suppressing DNA
rearrangements. This issue is important, because Alu elements are
so frequent in the human genome (one everyB3 kb on average),
are concentrated in gene-rich regions and are highly homologous
to each other. We tested whether demethylation promotes
rearrangements of SINEs using an assay that detects
translocations between two Alu copies targeted to chromosomes
14 and 17 in mouse ES cells40. Although much less common than
recombination between proximal Alu pairs, interchromosomal
translocations can be life-threatening1. For example, the Alu used
in this assay comes from intron 1 of the human MLL gene and
participates in MLL duplications that are found in patients with
acute myeloid leukaemia41. ChIP confirmed that this ectopic Alu
is selectively bound by pol III and MBPs in mouse ES cells, as
seen for multiple Alus in human cells (Fig. 4a; Supplementary
Fig. 17). Translocation is initiated using I-SceI endonuclease to
target a double-strand break specifically to the Alu loci. It is
detected using a split neomycin phosphotransferase gene (neo)
with an MLL Alu positioned downstream of a neo splice donor
site on chromosome 17 and another upstream of a neo splice
acceptor site on chromosome 14; reciprocal translocations
between the two sites generate functional neoþ genes that can
be detected by screening for neomycin-resistance (Fig. 8a). The
molecular basis of this resistance was confirmed by detection of
translocation-specific PCR products (Supplementary Fig. 18).
Treatment of these cells with 5-azacytidine releases MeCP2 and
MBD2 from the MLL-derived Alu elements (Fig. 4a). It also
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causes a significant increase in translocations (Fig. 8b; Supple-
mentary Data 2). Genomic translocations result from chromoso-
mal breakage and misrepair, especially of double-strand breaks.
We therefore tested whether the Alu-mediated translocations are
also induced by bleomycin, an agent that induces such breaks
efficiently but does not cause demethylation. In contrast to 5-
azacytidine, bleomycin failed to stimulate Alu translocation in
this system. This suggests that the increased rearrangements
induced by 5-azacytidine reflect its demethylating activity.
Discussion
Retrotransposons provide hotspots for genomic recombination.
They contain most of the methylated cytosines in human DNA
and this methylation is thought to suppress transposition to
promote genomic integrity42. Demethylation of satellite DNA
has been linked to chromosomal rearrangements and human
genetic disease39. Because SINEs are concentrated in and around
the protein-coding genes, their translocation can be especially
disruptive, as illustrated by many oncogenic rearrange-
ments2,43,44. For example, acute myeloid leukaemias have arisen
through recombination between intronic Alus, leading to partial
duplication of the MLL gene45–47. Using a model of such lesions,
we found that interchromosomal translocation between a pair of
Alu SINEs is suppressed by DNA methylation to a significant
degree (P¼ 0.0008, t-test). SINE-mediated rearrangements may,
therefore, contribute to the elevated mutation rates found in most
cancer cells where genomic hypomethylation is widespread48–50.
Indeed, hypomethylation of Alu DNA was found to correlate
(P¼ 0.008) with genomic instability in human lung carcinomas51.
Translocations between Alus arise when misrepair of a double-
strand break occurs through either of two pathways—non-
homologous end-joining or single-strand annealing40. The latter
predominates in the assay we have used. This remains the case
after treatment with 5-azacytidine (Supplementary Fig. 18),
suggesting that demethylation affects the frequency of these
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translocations, but not the repair pathway employed. However,
demethylation may also influence this assay indirectly by affecting
expression of the DNA repair machinery or the rearranged
reporter gene. We therefore regard this as an interesting but
preliminary observation. Further mechanistic analysis will be
required to establish whether methylation of Alu DNA affects
rearrangement frequency directly.
Although it may influence translocation, directly or indirectly,
SINE DNA methylation does not prevent transcription factor
occupancy or function under the conditions we have studied.
This was unexpected and contrasts with conclusions drawn from
several previous studies. DNA methylation was reported to
inhibit TFIIIC binding in vitro, but the DNA fragment tested
lacked clear promoter elements52. Increased Alu content was
found in RNA from lung cancer cell lines after treatment with
5-aza-20-deoxycytidine, but that study did not distinguish
between pol III products and Alu sequences embedded in pol II
transcripts51. However, the expression of pol III-initiated Alu
RNA was shown to be substantially elevated after 8 days
treatment of HeLa cells with 5-azacytidine6. Indirect effects
might have caused this response, given the long duration of
drug treatment. The authors confirmed that Alu loci were
demethylated6, but this does not prove that the Alu
demethylation was responsible directly for the observed
expression changes. Indeed, a study with U2OS cells found
that pol III transcripts are induced after 5 days treatment with
5-aza-20-deoxycytidine, but not after 2 days; in contrast, the p16
gene, which served as positive control, was induced4100-fold in
the 2-day-treated samples53. Although Alu transcripts were not
examined, each of five other pol III products tested showed
induction after 5 days but not after 2 days53. These data provide
clear evidence for secondary effects on the pol III machinery after
long-term treatment with demethylating agents. We used shorter
drug treatments (16–72 h), which were sufficient to cause SINE
demethylation and release of MBPs, but did not enhance
expression. Another study found that methylation of a chimeric
7SL/Alu reporter inhibited its expression in transfected cells;
contrary to expectation, cotransfection of a MeCP2
overexpression vector relieved this repression, rather than
compounding it17. This surprising result may reflect indirect
effects or the fact that transiently transfected reporters do not
adopt the chromatin structures of endogenous genes54. Clear
evidence that methylation of Alu DNA can directly inhibit its
transcription by pol III has been obtained using assays
in vitro13,15. However, the inhibitory effect in vitro was only
seen at low template concentrations and was absent when more
Alu DNA was used13,15. Our data suggest that the immunity to
repression seen with higher template concentrations mimics the
situation in vivo. Nuclear concentrations are orders of magnitude
higher than those employed for in vitro transcription reactions.
Perhaps, high local concentrations and the context of supercoiled
chromatin allow pol III to cope better with methylated templates
in situ than in dilute reactions in vitro. The failure of DNA
methylation to silence pol III transcription in cells is established
here through both genetic and pharmacological approaches.
Furthermore, unlike the previous studies, our expression data are
supported strongly by direct assessment of pol III occupancy on
SINEs and of the methylation state of pol III-bound SINE DNA.
The possibility remains, nevertheless, of a more dominant role for
DNA methylation in different cell types or conditions.
Although DNA methylation appears not to play a major role in
excluding pol III from its templates under the conditions we have
studied, trimethylation of H3K9 is clearly involved. This
modification was already known to be inversely correlated with
pol III occupancy and expression of tRNA genes37. We found that
inhibition of SUV39H1 selectively reduces H3K9 trimethylation
and stimulates pol III loading onto a subset of SINEs, while
raising expression of SINE transcripts substantially. An exception
is Alu(c6), where SUV39H1 inhibition did not significantly
alter H3K9me3 or pol III detection (Fig. 6b); this suggests that
some SINEs are targeted by H3K9 methyltransferases other
than SUV39H1. Local environment might dictate which
methyltransferase operates at individual SINEs.
In contrast to pol III, the binding of TFIIIC to SINEs is not
enhanced by inhibition of SUV39H1 (Fig. 6b). Indeed, TFIIIC
detection at SINEs is comparable to that at 7SL genes, which
attract much higher levels of pol III (Figs 2a,b and 6b). These
observations are consistent with the reports that TFIIIC can
overcome chromatin-mediated repression in vitro55,56. TFIIIC is
responsible for promoter recognition on most pol III-transcribed
genes, including SINEs, and then recruits TFIIIB and pol III by
protein–protein interactions26,57. We believe it is the pol III
recruitment step specifically that, rather than promoter
recognition, is inefficient in vivo at Alu, B1 and B2 SINEs.
Thus, quantification of multiple ChIP experiments revealed a
significantly higher ratio of pol III to TFIIIC on 7SL relative to
Alu (P¼ 0.007, t-test) in human cells and on 7SL relative to B1
(P¼ 0.002, t-test) and B2 (P¼ 0.003, t-test) in mouse cells. Since
pol III itself has minimal DNA sequence specificity, it is likely
to be the chromatin landscape of SINEs that discourages its
recruitment. Our data suggest that H3K9me3 is a feature of SINE
chromatin that impedes pol III recruitment and transcription.
Despite the inhibitory effects of chromatin, we were able to
detect pol III at B1,400 Alu SINEs across the human genome,
although with generally weaker binding than observed at active
tRNA genes. This contrasts with several previous studies that
recorded pol III occupancy of very few Alu SINEs38,58,59.
For example, only 13 Alu dimer loci were reported as pol III
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bound in ref. 38. The discrepancy may reflect a number of
technical differences, including the choice of statistical threshold.
Antibody efficiency may be especially important, as the pol III
antibody used in our current study gives unusually high
enrichment. Using the same pol III antibody as in our current
study, Moqtaderi et al.60 estimated that B1,000 SINEs were
pol III occupied in K562 cells, although the levels of pol III at
these loci were again generally much lower than at tRNA genes60.
There is onlyB2% overlap between the sets of Alu loci occupied
by pol III in the two studies, which used different cell types. This
suggests that access to SINEs may not only be limited, but also
highly variable according to conditions. As well as transcriptional
suppression, degradation of SINE RNA provides additional
protection against accumulation of their transcripts9.
Methods
Cell culture. HeLa cells and A31 fibroblasts were kindly provided by Peter Rigby.
Maria Jasin generously provided Hom Alu mouse ES cells, in which an Alu element
from intron 1 of the human MLL gene is carried within the Pim1 locus of
chromosome 17 and the Rb locus of chromosome 14 (ref. 40). Cells were cultured
in DMEM supplemented with 10% FCS, 2mM L-glutamine, 100Uml 1 penicillin
and 100Uml 1 streptomycin. For the Dnmt1þ /þ and Dnmt1 / fibroblasts,
kindly provided by Adrian Bird, Howard Cedar and Ittai Ben-Porath, medium was
supplemented with 2mM sodium pyruvate, 1% non-essential amino acids and
0.01% b-mercaptoethanol; these cells have a p53-null background27. 5-azacytidine
(Sigma) was used at 4 mM for 16–72 h, as indicated. Bleomycin (Calbiochem) was
used at 5 mgml 1 for 16 h. Treatment with chaetocin (Sigma) was for 24 h and
with a-amanitin (Sigma) was as indicated.
ChIP assays. ChIP–PCR and sequential ChIP–PCR assays were performed as
previously described61. Protein–DNA complexes were cross-linked using 1%
formaldehyde for 10min at room temperature and the reaction was quenched with
0.125M glycine. Cells were washed with PBS 0.5% NP-40 and lysed by incubation
in 1M NaCl PBS/NP-40, followed by 0.1M NaCl and 10mM TE/NP-40. The
nuclei were then cleaned by centrifugation through a 100mM sucrose cushion. The
chromatin was sheared by water bath sonication using a Bioruptor (Diagenode) to
obtain a median fragment size of 500 bp. Input samples were removed and
immunoprecipitation was performed overnight in 150mM NaCl TE/NP-40 using
5 mg antibody bound to protein A/G sepharose. Immunoprecipitates were washed
twice in RIPA buffer, twice in 250mM LiCl 0.5% Na-deoxycholate TE/NP-40,
twice in TE and elution was performed in TE/1%SDS. The eluate from the first
ChIP was diluted 1:10 before a sequential ChIP. Proteinase K digestion was
performed overnight at 42 C. DNA was purified with QIAquick PCR purification
kit (Qiagen), according to the manufacturers’ instructions.
Serial dilutions of the input chromatin were used to confirm that PCRs were
within a linear range. P values were obtained using a two-tailed unpaired t-test.
PCR primers and amplification conditions are described in Supplementary Table 1.
Individual loci were specified using primers for unique sequence flanking a
particular SINE. The B1(c9) and B2(c9) primers detect unique sequences on c9
within a cluster that has no recognized pol II transcription unit within 5 kb. B1 and
B2 primers detect subgroups of B102 family members each. The Alu consensus
primers match the PV subfamily that has B103 members.
For ChIP–chop assay24, ChIP DNA was spiked with 100 ng of unmethylated
PCR product containing a HpaII/MspI site (to normalize for digestion efficiency)
and then digested for 1 h with HpaII or MspI.
Antibodies used were M9317 against MeCP2 and M7318 against MBD2
(Sigma), IMG-306A against MBD1 (Imgenex), ab1791 against histone H3
(Abcam), 07-108 against histone H4 and 05-615 against SUV39H1 (Upstate),
9754S against H3K9me3 (Cell Signaling), sc-25366 against SUV39H1, sc-28735
against HP1, sc-25365 against TFIIA and sc-6571 against TAFI48 (Santa Cruz
Biotechnology), 1900 against the RPC155 subunit of Pol III62, 128 against the Brf1
subunit of TFIIIB, 4286 against the 110 kD subunit of TFIIIC63 and Ab7 against the
220 kD subunit of TFIIIC37. Uncropped scans are shown in Supplementary Fig. 19.
ChIP-BS-Seq library preparation and sequencing. For HeLa input DNA, two
libraries were prepared from the same input DNA: one with starting quantity of
10 ng, following the Illumina ChIP-Seq library protocol, with the addition of
bisulfite conversion after addition of adaptors but before amplification; and one
following the Illumina Bisulfite Sequencing protocol, including the recommended
starting amount. All libraries included addition of 2% sheared lambda DNA to
control for bisulfite conversion. The Qiagen EpiTect kit was used for bisulfite
conversion, with four periods of incubation at 60 C (for 25, 85, 175 and 120min),
each preceded by denaturation for 10min at 98 C. Size selection was not per-
formed for the amplified libraries (except the regular input library) due to the small
insert size and the small total amount of total library after amplification. The first
library was subjected to 101-cycle paired-end sequencing (one lane) and the second
library was subjected to 101-cycle single-end sequencing (one lane) on the Illumina
HiSeq. For pol III ChIP-BS-Seq, one library was prepared with eluate from 10
technical replicate RPC155 ChIP assays carried out as previously38 (B10 ng; all
replicates were from the same batch of cross-linked HeLa cells, grown to 75%
confluence), following the Illumina ChIP-Seq library protocol with bisulfite
conversion as for the first input library. The pol III library was subjected to
101-cycle single-end sequencing (three lanes) on the Illumina HiSeq.
ChIP-BS-Seq analysis. A novoalign index was created for the hg18 genome
(UCSC), plus the Lambda genome (Genbank accession number J02459.1) and
adapter sequences (Illumina PE PCR Primer 2.0) with these options: novoindex -k
13 -s 3 -b. Reads were aligned with novoalign using paired-end (-FILMFQ -t120
-h120 -b2 -a -i PE 20–600) or single-end settings (-FILMFQ -t120 -h120 -b2 -a).
Repeat alignments intersecting at least one uniquely aligned sequence realigned
using single-end settings, allowing up to seven alignments (-r A 7), which includes
85% of the repeat reads. For input, we obtained 94122299 genomic alignments
(86740371 uniquely aligned reads and 2491119 reads with 2–7 alignments); for
RPC155, we obtained 43883712 genomic alignments (37007535 uniquely aligned
reads and 2694788 reads with 2–7 alignments). In addition, 1344324 reads of the
input library and 1187215 reads of the pol III library aligned to the Lambda
genome. The rates of conversion of methylated cytosines in the reads aligning to
Lambda are 99.87% and 99.64% for input and pol III libraries, respectively.
Analysis of aligned data was performed with the USeq package of programs
(useq.sourceforce.net). For ChIP-Seq analysis, alignments were converted to single-
position point data with NovoalignParser (with no quality filter, to include repeat
alignments) and peaks were called with ScanSeqs (using peakshift of 116 bp, as
determined by PeakShiftFinder, and 300 bp window) and EnrichedRegionMaker
with thresholds of 20 or 70, 13 and 1 for Q-value false discovery rate (FDR),
empirical FDR and log2 ratio, respectively. To obtain a list of enriched pol III-
transcribed genes (including SINEs), pol III-enriched regions (Q-value 20
threshold) were intersected with an annotation file containing all SINEs, tRNA
genes and fragments, and other pol III-transcribed genes and elements from the
RepeatMasker track of UCSC. The annotated genes/repeat elements were scored by
DefinedRegionScanSeqs using the PointData and Q-value 70 threshold was used.
The number of enriched genes by class is 1,472 Alu, 242 tRNA, 83 MIR, seven U6,
four hY, three 7SL/SRP, three HVG, two 5S rRNA, two miRNA, one RNaseP,
one MRP, one BC200 and one 7SK to a total of 1,822 genes.
For methylation analysis, alignments were converted to per-base methylated
and unmethylated cytosines with NovoalignBisulfitParser (with no quality filter to
include repeat alignments). Regions statistically enriched or reduced for
methylation were determined with BisSeq (using settings -w 10 -m 10 -f 13 -l 0).
Percent methylation scores for enriched pol III target genes (including SINEs) were
obtained using ScoreMethylatedRegions.
To compare pol III enrichment scores and methylation fractions between Alu
families (for example, AluJ, AluS and AluY), a non-parametric Kruskal–Wallis test
was performed, followed by Dunn’s multiple comparison test.
For alignment of reads to the Alu consensus sequences, Alu sequences were
obtained from Repbase and concatenated with 100xN separating the sequences.
This fasta file was indexed with novoindex. Genomic reads were filtered for those
intersecting with SINEs, converted to fastq format and realigned to the Alu
consensus index with novoalign (-r All 14 -t240 -h120 -b2 -a -s). Per-base cytosine
methylation graphs were obtained with BisStat and visualized with IGB
(www.bioviz.org).
Affinity chromatography. Separation of genomic DNA according to CpG
methylation status was achieved by affinity chromatography with immobilized
recombinant MBD2b and MBD3L1 using a MethylCollector Ultra (Active Motif),
according to the manufacturer’s specifications.
Gene expression analysis. To synthesize complementary DNA for RT–PCR,
SuperScript III reverse transcriptase (Invitrogen) was used as previously61, with
200 ng of RNA and Hexanucleotide Mix (Roche). Primers and amplification
conditions are described in Supplementary Table 1. Primer extension was
performed using 5-carboxyfluorescein end-labelled (Invitrogen) Alu 21mer primer.
RNA (5–10 mg) was denatured with 100 ng of labelled probe in 20 ml of 1 First
Strand Buffer (Invitrogen) at 80 C for 10min. Primer annealing was performed at
56 C for 2 h. Thirty microlitre of elongation mix containing 100U of SuperScript
III (Invitrogen), 1:50 RNAsin (Promega), 2mM dithiothreitol, 1mM dNTP and
10 ng ml 1 actinomycin D (Sigma) were added and samples were incubated at
42 C for 1 h. Nucleic acids were precipitated in 0.1M NaOAc and ethanol
overnight with 1 ml of 1M purified yeast tRNA as carrier. Samples were resolved on
7% sequencing gels and visualized using Typhoon 9400 (GE Healthcare). All P
values were obtained using a two-tailed unpaired t-test.
Translocation assay. Culture of Hom Alu mouse ES cells and translocation assays
were conducted as previously40. Cells (107) were electroporated with 25 mg of
pTK-hyg or pCBAS and were allowed to recover from electroporation for 10 h
before treatment for 16 h with 5-azacytidine or bleomycin. Cells were then allowed
to recover in growth medium for 24 h and then subjected to selection with
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200mgml 1 neomycin for 8–10 days. A plate without selection was used to
calculate the loss of cell viability due to drug treatment. Colonies obtained after
selection were GIEMSA stained for counting or picked for PCR analysis.
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